Skip to main content

Greenland Capital Management LP

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1896430 NEW YORK, NY

Position in BMRN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,144,400
+$121,931 QoQ
Shares Held
20,000
+10.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#258
of 555 holders
Holding Since
Dec 2024
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Jun 30, 2026
CallValue
$2,288,800
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Greenland Capital Management LP holds $9,138,618 across 8 Biotechnology names. BMRN ranks #3 (12.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BMRN
Biomarin Pharmaceutical Inc
This page
20,000 $1,144,400

All Filings in BMRN

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,144,400 20,000
2026-06-30 $2,288,800 40,000
2026-03-31 $1,977,150 35,000
2026-03-31 $1,022,469 18,100
2024-12-31 $232,684 3,540